Chinese Medical Journal (Mar 2024)
Effects of dual antiplatelet therapy de-escalation on the prognosis of acute coronary syndrome patients at high risk of ischemia who underwent percutaneous coronary intervention
- Jingyao Wang,
- Yachao Li,
- Mengjie Lei,
- Yanli Yang,
- Haiyan Gao,
- Xiangjin Wang,
- Lei An,
- Haili Zhou,
- Xue Sun,
- Cairong Li,
- Zhigang Zhao,
- Zengming Xue,
- Rongman Jia
Affiliations
- Jingyao Wang
- Department of Cardiology, Langfang People’s Hospital, Hebei Medical University, Langfang Core Laboratory of Precision Treatment of Coronary Artery Disease, Langfang, Hebei 065000, China
- Yachao Li
- Department of Cardiology, Langfang People’s Hospital, Hebei Medical University, Langfang Core Laboratory of Precision Treatment of Coronary Artery Disease, Langfang, Hebei 065000, China
- Mengjie Lei
- Department of Cardiology, Langfang People’s Hospital, Hebei Medical University, Langfang Core Laboratory of Precision Treatment of Coronary Artery Disease, Langfang, Hebei 065000, China
- Yanli Yang
- Department of Cardiology, Langfang People’s Hospital, Hebei Medical University, Langfang Core Laboratory of Precision Treatment of Coronary Artery Disease, Langfang, Hebei 065000, China
- Haiyan Gao
- Department of Cardiology, Langfang People’s Hospital, Hebei Medical University, Langfang Core Laboratory of Precision Treatment of Coronary Artery Disease, Langfang, Hebei 065000, China
- Xiangjin Wang
- Department of Cardiology, Langfang People’s Hospital, Hebei Medical University, Langfang Core Laboratory of Precision Treatment of Coronary Artery Disease, Langfang, Hebei 065000, China
- Lei An
- Department of Cardiology, Langfang People’s Hospital, Hebei Medical University, Langfang Core Laboratory of Precision Treatment of Coronary Artery Disease, Langfang, Hebei 065000, China
- Haili Zhou
- Department of Cardiology, Langfang People’s Hospital, Hebei Medical University, Langfang Core Laboratory of Precision Treatment of Coronary Artery Disease, Langfang, Hebei 065000, China
- Xue Sun
- Department of Cardiology, Langfang People’s Hospital, Hebei Medical University, Langfang Core Laboratory of Precision Treatment of Coronary Artery Disease, Langfang, Hebei 065000, China
- Cairong Li
- Department of Cardiology, Langfang People’s Hospital, Hebei Medical University, Langfang Core Laboratory of Precision Treatment of Coronary Artery Disease, Langfang, Hebei 065000, China
- Zhigang Zhao
- Department of Cardiology, Langfang People’s Hospital, Hebei Medical University, Langfang Core Laboratory of Precision Treatment of Coronary Artery Disease, Langfang, Hebei 065000, China
- Zengming Xue
- Department of Cardiology, Langfang People’s Hospital, Hebei Medical University, Langfang Core Laboratory of Precision Treatment of Coronary Artery Disease, Langfang, Hebei 065000, China
- Rongman Jia
- DOI
- https://doi.org/10.1097/CM9.0000000000003011
- Journal volume & issue
-
Vol. 137,
no. 6
pp. 746 – 748
Abstract
No abstracts available.
